NCT02282644 Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry Status COMPLETED Phase NA
NCT02282137 68Ga-PSMA PET-CT Scan for Diagnosis and Management of Prostate Cancer Status UNKNOWN Phase PHASE2
NCT02280356 Radiation Therapy in Combination With Brachytherapy for Clinically Localized, Intermediate Risk Prostate Cancer Status COMPLETED Phase PHASE2
NCT02279862 Safety and Efficacy Study of Ipilimumab 3 mg/kg Versus Ipilimumab 10 mg/kg in Subjects With Metastatic Castration Resistant Prostate Cancer Who Are Chemotherapy Naive Status COMPLETED Phase PHASE2
NCT02279693 Evaluation of the Dose Received by the Prostate With in Vivo Dosimetry in Patients Treated With Daily IGRT Associated With IMRT Using Two Repositioning Techniques for Localized Prostate Cancer Status TERMINATED Phase NA
NCT02274779 Salvage Radiotherapy Combined With Hormonotherapy in Oligometastatic Pelvic Node Relapses of Prostate Cancer Status COMPLETED Phase PHASE2
NCT02274623 Effect of CTAP101 Capsules on Ca/iPTH in Advanced Breast/Prostate Cancer Patients Treated With Denosumab/Zoledronic Acid Status COMPLETED Phase PHASE1
NCT02271659 Medical and Economic Evaluation for Intermediate-risk Prostate Cancer Status UNKNOWN Phase NA
NCT02269982 Prospective CiRculating prOstate Cancer Predictors in HighEr Risk mCRPC studY Status COMPLETED Phase N/A
NCT02265159 Intervention Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound for the Treatment of Prostate Cancer Status UNKNOWN Phase PHASE2/PHASE3
NCT02264379 Percutaneous High-dose Radiotherapy in Patients With Oligometastases of Prostate Carcinoma Status COMPLETED Phase N/A
NCT02262910 Study of ES414 in Metastatic Castration-Resistant Prostate Cancer Status COMPLETED Phase PHASE1
NCT02257827 Trial Comparing Intensity Modulated Radiotherapy Versus Conformal Radiotherapy to Treat Prostate Cancer With Hypofractionated Schedule Status COMPLETED Phase PHASE3
NCT02255890 Registry of Irreversible Electroporation for the Ablation of Prostate Cancer With Use of Nanoknife Device Status UNKNOWN Phase N/A
NCT02252978 Ciprofloxacin Compared to Placebo in Diagnosing Prostate Cancer in Patients Undergoing Prostate Biopsy Status WITHDRAWN Phase PHASE2